Sinovac Biotech Co., Ltd. (filling, packaging, quality control, batch release; production of unpackaged vaccine (inactivated split-virus influenza (virions)))

Ukraine

All drugs from this manufacturer

SPLIT-VACCINE FOR PREVENTION OF INFLUENZA QUADRIVALENT, INACTIVATED

The drug is intended for active immunization of adults and children aged 3 years and older for the prevention of influenza, especially in individuals at increased risk of complications.

Dosage form: suspension for injection

Active substance	Dosage
inactivated split influenza virus a/victoria/4897/2022 (h1n1)pdm09	15 mcg
inactivated split influenza virus a/croatia/10136rv/2023 (h3n2)	15 mcg
inactivated split influenza virus b/austria/1359417/2021 (b/victoria lineage)	15 mcg
inactivated influenza split virus b/phuket/3073/2013 (b/yamagata lineage)	15 mcg

ATC: J07BB02